Pariser D, Sussman J, Martin B, Ackerman L, Kraffert C, Jarell A. Real-World Evidence Confirms Risk Stratification of the 31-GEP and i31-GEP in Prospectively Tested Patients with Stage I-III Cutaneous Melanoma . J of Skin [Internet]. 2024Mar.18 [cited 2024Sep.20];8(2):s386. Available from: https://dermsquared.com/skin/article/view/2596